Stay informed with the latest litigation news. Explore now

IP Verse

Biontech Cell&gene Therapies competitive analysis

Latest publications and patents of Biontech Cell&gene Therapies New

Explore the latest publications and patents granted to Biontech Cell&gene Therapies, showcasing their recent innovations and technological advancements.

Last updated on: Sep 3, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biontech Cell&gene Therapies

EP3294325
Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid VaccinationGranted And Under Opposition
EP3126381
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell EpitopesPatent Maintained As Amended
EP3294333
Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell EpitopesGranted And Under Opposition

Latest patents of Biontech Cell&gene Therapies opposed by its competitors

Explore Biontech Cell&gene Therapies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3294325
Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
EP3126381
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
EP3294333
Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1

Latest PTAB cases involving Biontech Cell&gene Therapies New

Discover the latest PTAB cases involving Biontech Cell&gene Therapies, highlighting their recent legal challenges and patent disputes.

Top competitors of Biontech Cell&gene Therapies

Top competitors of Biontech Cell&gene Therapies based on patent oppositions.